Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2010 1
2011 4
2012 3
2013 3
2014 3
2015 4
2016 6
2017 3
2018 9
2019 5
2020 2
2021 3
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
Hamada T, Takahashi H, Nakagawa M, Nukariya H, Ito S, Endo T, Kurihara K, Koike T, Iizuka K, Ohtake S, Ichinohe T, Maebayashi T, Miura K, Hatta Y, Nakamura H. Hamada T, et al. Among authors: takahashi h. Case Rep Oncol. 2023 May 22;16(1):338-346. doi: 10.1159/000530265. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37384208 Free PMC article.
Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
Takahashi H, Miura K, Nakagawa M, Nishimaki H, Ito S, Nukariya H, Kurihara K, Endo T, Koike T, Hamada T, Iizuka K, Ohatake S, Iriyama N, Nakayama T, Masuda S, Hatta Y, Nakamura H. Takahashi H, et al. Hematol Oncol. 2022 Dec;40(5):1094-1096. doi: 10.1002/hon.3043. Epub 2022 Jul 8. Hematol Oncol. 2022. PMID: 35781821 Clinical Trial. No abstract available.
Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Miura K, Takahashi H, Nakagawa M, Hamada T, Uchino Y, Iizuka K, Ohtake S, Iriyama N, Hatta Y, Nakamura H. Miura K, et al. Among authors: takahashi h. Expert Rev Anticancer Ther. 2022 Jun;22(6):583-595. doi: 10.1080/14737140.2022.2071262. Epub 2022 May 5. Expert Rev Anticancer Ther. 2022. PMID: 35472312 Review.
Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma.
Noguchi Y, Iriyama N, Takahashi H, Uchino Y, Nakagawa M, Hamada T, Iizuka K, Koike T, Kurihara K, Endo T, Yoshida T, Miura K, Nakayama T, Hatta Y, Takei M. Noguchi Y, et al. Among authors: takahashi h. Cancer Diagn Progn. 2021 May 3;1(2):35-42. doi: 10.21873/cdp.10006. eCollection 2021 May-Jun. Cancer Diagn Progn. 2021. PMID: 35403126 Free PMC article.
Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma.
Nakagawa M, Iriyama N, Ishikawa T, Miura K, Uchino Y, Takahashi H, Hamada T, Iizuka K, Koike T, Kurihara K, Nakayama T, Hatta Y, Takei M. Nakagawa M, et al. Among authors: takahashi h. Cancer Diagn Progn. 2021 Jul 3;1(3):221-229. doi: 10.21873/cdp.10030. eCollection 2021 Jul-Aug. Cancer Diagn Progn. 2021. PMID: 35399319 Free PMC article.
49 results